Peng Luo

11.2k total citations · 10 hit papers
389 papers, 6.1k citations indexed

About

Peng Luo is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peng Luo has authored 389 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 140 papers in Molecular Biology, 127 papers in Oncology and 108 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peng Luo's work include Cancer Immunotherapy and Biomarkers (69 papers), Ferroptosis and cancer prognosis (63 papers) and Lung Cancer Treatments and Mutations (26 papers). Peng Luo is often cited by papers focused on Cancer Immunotherapy and Biomarkers (69 papers), Ferroptosis and cancer prognosis (63 papers) and Lung Cancer Treatments and Mutations (26 papers). Peng Luo collaborates with scholars based in China, United States and Hong Kong. Peng Luo's co-authors include Jian Zhang, Anqi Lin, Quan Cheng, Zaoqu Liu, Hao Zhang, Ting Wei, Zaoqu Liu, Nan Zhang, Xinwei Han and Yuqing Ren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Peng Luo

347 papers receiving 6.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosenescence: molecular mechanisms and diseases

2023 421 citations Zaoqu Liu, Yuqing Ren et al. profile →
Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer

2020 246 citations Anqi Lin, Jian Zhang et al. profile →
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials

2023 228 citations Hao Zhang, Wantao Wu et al. profile →
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts

2022 174 citations Hao Zhang, Zeyu Wang et al. profile →
Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

2023 114 citations Chaozheng Zhou, Anqi Lin et al. profile →
CTLs heterogeneity and plasticity: implications for cancer immunotherapy

2024 62 citations Anqi Lin, Aimin Jiang et al. profile →
iMLGAM: Integrated Machine Learning and Genetic Algorithm‐driven Multiomics analysis for pan‐cancer immunotherapy response prediction

2025 57 citations Bicheng Ye, Peng Luo et al. profile →
Multi-stage mechanisms of tumor metastasis and therapeutic strategies

2024 54 citations Zaoqu Liu, Yuqing Ren et al. profile →
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review

2024 54 citations Aimin Jiang, Anqi Lin et al. Journal of Translational Medicine profile →
Regulation of cellular senescence in tumor progression and therapeutic targeting: mechanisms and pathways

2025 23 citations Hao Zhang, Nan Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peng Luo China	39	2.3k	2.0k	1.4k	1.3k	1.2k	389	6.1k
Jiuwei Cui China	44	3.1k 1.4×	2.6k 1.3×	1.4k 1.0×	1.6k 1.2×	1.8k 1.5×	361	7.4k
Xiaoling Li China	45	3.6k 1.6×	1.4k 0.7×	1.1k 0.8×	1.3k 1.0×	1.8k 1.5×	224	6.9k
Ding Ma China	37	2.8k 1.2×	1.7k 0.8×	1.0k 0.7×	771 0.6×	1.9k 1.6×	202	5.7k
Junjie Wang China	35	1.7k 0.7×	1.4k 0.7×	1.2k 0.8×	965 0.7×	1.1k 0.9×	296	5.3k
Jun Zhang China	51	3.7k 1.6×	2.5k 1.2×	1.9k 1.3×	967 0.7×	1.8k 1.5×	419	8.9k
Liping Wang China	36	1.6k 0.7×	2.1k 1.0×	835 0.6×	1.7k 1.3×	633 0.5×	233	5.4k
Yifan Wang China	37	3.0k 1.3×	2.4k 1.2×	870 0.6×	1.1k 0.9×	1.1k 0.9×	194	7.1k
Xiaochen Wang China	37	2.6k 1.1×	1.1k 0.5×	707 0.5×	803 0.6×	1.6k 1.4×	204	5.3k
Haiyan Li China	40	2.7k 1.2×	1.2k 0.6×	715 0.5×	948 0.7×	1.3k 1.0×	270	5.8k
Qingyu Wu China	51	2.3k 1.0×	1.0k 0.5×	844 0.6×	1.0k 0.8×	1.1k 0.9×	233	7.7k

Countries citing papers authored by Peng Luo

Since Specialization

Citations

This map shows the geographic impact of Peng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Luo more than expected).

Fields of papers citing papers by Peng Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Luo. The network helps show where Peng Luo may publish in the future.

Co-authorship network of co-authors of Peng Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Peng Luo. A scholar is included among the top collaborators of Peng Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peng Luo. Peng Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiu, Wenjun, Qiyun Ou, Jiani Wu, et al.. (2025). Artificial Intelligence‐Based Multimodal Prediction of Postoperative Adjuvant Immunotherapy Benefit in Urothelial Carcinoma: Results From the Phase III, Multicenter, Randomized, IMvigor010 Trial. MedComm. 6(9). e70324–e70324.

Liu, Zaoqu, Yuhao Ba, Dan Shan, et al.. (2025). THBS2-producing matrix CAFs promote colorectal cancer progression and link to poor prognosis via the CD47-MAPK axis. Cell Reports. 44(4). 115555–115555. 4 indexed citations

Lin, Anqi, Aimin Jiang, Li Chen, et al.. (2025). Large language models in clinical trials: applications, technical advances, and future directions. BMC Medicine. 23(1). 563–563. 1 indexed citations

Jiang, Aimin, Weiming Mou, Dongqiang Zeng, et al.. (2025). Temporal evolution of large language models (LLMs) in oncology. Journal of Translational Medicine. 23(1). 1219–1219.

Ren, Yuqing, Yi Yue, Xinyang Li, et al.. (2024). Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy. International Immunopharmacology. 142(Pt A). 113147–113147. 7 indexed citations

Luo, Peng, et al.. (2024). Potential COX-2 inhibitors modulating NF-κB/MAPK signaling pathways: Design, synthesis and evaluation of anti-inflammatory activity of Pterostilbene-carboxylic acid derivatives with an oxime ether moiety. Bioorganic & Medicinal Chemistry. 118. 118022–118022. 1 indexed citations

Jiang, Aimin, Wenqiang Liu, Qiwei Yang, et al.. (2024). TDERS, an exosome RNA-derived signature predicts prognosis and immunotherapeutic response in clear cell renal cell cancer: a multicohort study. SHILAP Revista de lepidopterología. 4(4). 382–394. 3 indexed citations

Lin, Weiyin, Hong Yang, Xia Yang, et al.. (2024). OralExplorer: a web server for exploring the mechanisms of oral inflammatory diseases. Journal of Translational Medicine. 22(1). 1 indexed citations

Zhang, Zhuoyuan, et al.. (2024). FBL Promotes LPS-Induced Neuroinflammation by Activating the NF-κB Signaling Pathway. Journal of Inflammation Research. Volume 17. 2217–2231. 4 indexed citations

10.

Dang, Qin, Zhaokai Zhou, Shuang Chen, et al.. (2024). Molecular subtypes of colorectal cancer in the era of precision oncotherapy: Current inspirations and future challenges. Cancer Medicine. 13(14). e70041–e70041. 5 indexed citations

11.

Jiang, Aimin, Jinxin Li, Ying Liu, et al.. (2024). Renal cancer: signaling pathways and advances in targeted therapies. SHILAP Revista de lepidopterología. 5(8). e676–e676. 9 indexed citations

12.

Wen, Jie, Hao Zhang, Nan Zhang, et al.. (2024). Large-scale genome-wide association studies reveal the genetic causal etiology between air pollutants and autoimmune diseases. Journal of Translational Medicine. 22(1). 392–392. 41 indexed citations

13.

Jiang, Aimin, Zi‐jun Xu, Xiao Fang, et al.. (2023). RNA modification pattern‐based subtypes reveal heterogenous clinical outcomes and tumor immunity of clear cell renal cell carcinoma. SHILAP Revista de lepidopterología. 2(1). 7 indexed citations

14.

Luo, Peng, Guojun Chen, Jin Yang, et al.. (2023). Comprehensive multi-omics analysis of tryptophan metabolism-related gene expression signature to predict prognosis in gastric cancer. Frontiers in Pharmacology. 14. 1267186–1267186. 4 indexed citations

15.

Qu, Chunfeng, Rongxin He, Wanyin Hou, et al.. (2023). Global burden of neoplasms attributable to specific occupational carcinogens over 30 years: a population-based study. Public Health. 223. 145–155. 1 indexed citations

16.

Xia, Kai, Fulin Wang, Suyuan Zhang, et al.. (2023). Precise Correction of Lhcgr Mutation in Stem Leydig Cells by Prime Editing Rescues Hereditary Primary Hypogonadism in Mice. Advanced Science. 10(29). e2300993–e2300993. 12 indexed citations

17.

Xiang, Guangheng, et al.. (2023). A nomogram for prediction of deep venous thrombosis risk in elderly femoral intertrochanteric fracture patients: A dual-center retrospective study. Frontiers in Surgery. 9. 1028859–1028859. 2 indexed citations

18.

Zhang, Nan, Hao Zhang, Zaoqu Liu, et al.. (2023). An artificial intelligence network‐guided signature for predicting outcome and immunotherapy response in lung adenocarcinoma patients based on 26 machine learning algorithms. Cell Proliferation. 56(4). e13409–e13409. 46 indexed citations

19.

Zhou, Chaozheng, et al.. (2023). Profiles of immune infiltration in seasonal allergic rhinitis and related genes and pathways. International Immunopharmacology. 120. 110174–110174. 2 indexed citations

20.

Lin, Anqi, Ting Wei, Mengyao Li, et al.. (2022). CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer. Briefings in Bioinformatics. 23(3). 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact